Your browser doesn't support javascript.
loading
DYNAMO: A Phase II Study of Duvelisib (IPI-145) in Patients With Refractory Indolent Non-Hodgkin Lymphoma.
Flinn, Ian W; Miller, Carole B; Ardeshna, Kirit M; Tetreault, Scott; Assouline, Sarit E; Mayer, Jiri; Merli, Michele; Lunin, Scott D; Pettitt, Andrew R; Nagy, Zoltan; Tournilhac, Olivier; Abou-Nassar, Karem-Etienne; Crump, Michael; Jacobsen, Eric D; de Vos, Sven; Kelly, Virginia M; Shi, Weiliang; Steelman, Lori; Le, NgocDiep; Weaver, David T; Lustgarten, Stephanie; Wagner-Johnston, Nina D; Zinzani, Pier Luigi.
Afiliación
  • Flinn IW; 1 Sarah Cannon Research Institute, Nashville, TN.
  • Miller CB; 2 Tennessee Oncology, Nashville, TN.
  • Ardeshna KM; 3 Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD.
  • Tetreault S; 4 University College London Hospitals National Health Service Foundation Trust, London, United Kingdom.
  • Assouline SE; 5 Florida Cancer Specialists, Tallahassee, FL.
  • Mayer J; 6 McGill University, Montreal, Quebec, Canada.
  • Merli M; 7 Fakultní Nemocnice Brno, Brno, Czech Republic.
  • Lunin SD; 8 Ospedale di Circolo e Fondazione Macchi, Varese, Italy.
  • Pettitt AR; 5 Florida Cancer Specialists, Tallahassee, FL.
  • Nagy Z; 9 University of Liverpool, Liverpool, United Kingdom.
  • Tournilhac O; 10 Semmelweis Egyetem, Budapest, Hungary.
  • Abou-Nassar KE; 11 Centre Hospitalier Universitaire Estaing, Clermont-Ferrand, France.
  • Crump M; 12 Centre intégré de santé et de services sociaux de l'Outaouais, Gatineau, Quebec, Canada.
  • Jacobsen ED; 13 Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • de Vos S; 14 Dana-Farber Cancer Institute, Boston, MA.
  • Kelly VM; 15 Ronald Reagan University of California, Los Angeles, Medical Center, Los Angeles, CA.
  • Shi W; 16 Infinity Pharmaceuticals, Cambridge, MA.
  • Steelman L; 16 Infinity Pharmaceuticals, Cambridge, MA.
  • Le N; 16 Infinity Pharmaceuticals, Cambridge, MA.
  • Weaver DT; 17 Verastem Oncology, Needham, MA.
  • Lustgarten S; 17 Verastem Oncology, Needham, MA.
  • Wagner-Johnston ND; 17 Verastem Oncology, Needham, MA.
  • Zinzani PL; 18 Washington University in St Louis, St Louis, MO.
J Clin Oncol ; 37(11): 912-922, 2019 04 10.
Article en En | MEDLINE | ID: mdl-30742566
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Purinas / Linfoma no Hodgkin / Resistencia a Antineoplásicos / Inhibidores Enzimáticos / Isoquinolinas Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Clin Oncol Año: 2019 Tipo del documento: Article País de afiliación: Túnez Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Purinas / Linfoma no Hodgkin / Resistencia a Antineoplásicos / Inhibidores Enzimáticos / Isoquinolinas Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Clin Oncol Año: 2019 Tipo del documento: Article País de afiliación: Túnez Pais de publicación: Estados Unidos